Effects of Pazopanib, Sunitinib, and Sorafenib, Anti-VEGF Agents, on the Growth of Experimental Endometriosis in Rats

Activation of AMP-activated protein kinase by retinoic acid sensitizes hepatocellular carcinoma cells to apoptosis induced by sorafenib

(2015) Naoki Ishijima et al.   CANCER SCIENCE

p27kip1 overexpression regulates VEGF expression, cell proliferation and apoptosis in cell culture from eutopic endometrium of women with endometriosis

(2014) G. A. Gonçalves et al.   APOPTOSIS

Pregnancy affects morphology of induced endometriotic lesions in a mouse model through alteration of proliferation and angiogenesis

(2014) J. Cohen et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

In vitroeffect of IL-2 in combination with pazopanib or sunitinib on lymphocytes function and apoptosis of RCC cells

(2014) Alaaeldin Shablak et al.   EXPERT OPINION ON PHARMACOTHERAPY

Molecular aspects of development and regulation of endometriosis

(2014) Yana B Aznaurova et al.   Reproductive Biology and Endocrinology

Vascular endothelial growth factor C is increased in endometrium and promotes endothelial functions, vascular permeability and angiogenesis and growth of endometriosis

(2013) Hui Xu et al.   ANGIOGENESIS

Sunitinib as an anti-endometriotic agent

(2013) Manal A. Abbas et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

The C-Kit Receptor-Mediated Signal Transduction and Tumor-Related Diseases

(2013) Jing Liang et al.   International Journal of Biological Sciences

Antiproliferative and Proapoptotic Activity of Sunitinib on Endothelial and Anaplastic Thyroid Cancer Cells via Inhibition of Akt and ERK1/2 Phosphorylation and by Down-Regulation of Cyclin-D1

(2013) Teresa Di Desidero et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Animal models for anti-angiogenic therapy in endometriosis

(2013) Andrew K. Edwards et al.   JOURNAL OF REPRODUCTIVE IMMUNOLOGY

Involvement of the Wnt/β-Catenin Signaling Pathway in the Cellular and Molecular Mechanisms of Fibrosis in Endometriosis

(2013) Sachiko Matsuzaki et al.   PLoS One

Sorafenib inhibits growth, migration, and angiogenic potential of ectopic endometrial mesenchymal stem cells derived from patients with endometriosis

(2012) Aldo Moggio et al.   FERTILITY AND STERILITY

Pathogenesis and pathophysiology of endometriosis

(2012) Richard O. Burney et al.   FERTILITY AND STERILITY

The Efficacy of Bevacizumab, Sorafenib, and Retinoic Acid on Rat Endometriosis Model

(2012) Hatice Ozer et al.   Reproductive Sciences

Antiangiogenic effects of pazopanib in xenograft hepatocellular carcinoma models: evaluation by quantitative contrast-enhanced ultrasonography

(2011) Xiao-Dong Zhu et al.   BMC CANCER

Aberrant Expression of Apoptosis-Related Molecules in Endometriosis

(2011) Kaei Nasu et al.   Reproductive Sciences

Expression of oct-4 and c-kit antigens in endometriosis

(2010) Arianna Pacchiarotti et al.   FERTILITY AND STERILITY

Higher expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 (Flk-1) and metalloproteinase-9 (MMP-9) in a rat model of peritoneal endometriosis is similar to cancer diseases

(2010) Daniel E Machado et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Endometriosis

(2009) Serdar E. Bulun   NEW ENGLAND JOURNAL OF MEDICINE

Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling

(2008) Scott M. Wilhelm et al.   MOLECULAR CANCER THERAPEUTICS

Mechanistic and Therapeutic Implications of Angiogenesis in Endometriosis

(2008) Robert N. Taylor et al.   Reproductive Sciences